Professional Experience
Dr. Specht has held prominent positions in both clinical and academic oncology, demonstrating leadership and extensive hands-on experience in cancer treatment.
- Chief Oncologist: Rigshospitalet, Department of Oncology, Copenhagen, Denmark
- Clinical Professor: Department of Clinical Medicine, University of Copenhagen
- Senior House Officer: Department of Medicine, Roskilde Hospital, Denmark
- House Officer: Department of Medicine, Copenhagen Municipal Hospital, Denmark
- House Officer: Department of Oncology I, The Finsen Institute, Denmark
- Locum Junior House Officer: Department of Medicine, York District Hospital, England
Academic Contributions
Dr. Specht has made significant academic contributions through teaching, mentorship, and research initiatives. Her work has shaped the training of new oncologists and advanced the understanding of cancer treatment.
- Lecturer and Mentor: University of Copenhagen, Department of Clinical Medicine
- Research Fellow: Danish Cancer Society
- Course Developer and Speaker: International oncology conferences and training programs
- Research Interests: Prognostic factors in Hodgkin lymphoma, late effects of cancer treatment, advanced radiation therapy techniques
Areas of Expertise
Dr. Specht specializes in treating complex cancer cases using advanced techniques, with a focus on improving patient outcomes and minimizing side effects.
- Lymphoma: Treatment of Hodgkin and non-Hodgkin lymphoma, early and advanced stages
- Head and Neck Cancer: Radiotherapy planning and treatment for tumors in the head and neck region
- Radiation Oncology: Precision radiotherapy and imaging strategies
- Late Effects of Cancer Treatment: Management and prevention of post-treatment complications
Publications and Research
Dr. Specht has authored over 330 peer-reviewed publications, contributing to the global knowledge of oncology. Her research has influenced clinical practice guidelines and patient care standards.
- Position Emission Tomography with or without Computed Tomography in the Primary Staging of Hodgkin’s Lymphoma: Evaluates PET/CT in staging Hodgkin’s lymphoma
- FDG-PET after Two Cycles of Chemotherapy Predicts Treatment Failure and Progression-Free Survival in Hodgkin Lymphoma: Assesses early PET scans for predicting treatment response
- Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Investigates innovative treatments for radiation-induced side effects
For additional publications, her profiles can be found on PubMed, ResearchGate, and ORCID.
Patient Care Philosophy
Dr. Specht emphasizes a patient-centered approach to oncology, prioritizing communication, empathy, and education to empower patients throughout their treatment journey.
- Effective Communication: Ensures patients understand diagnoses, treatment plans, and expected outcomes
- Empathy: Provides compassionate care during all stages of treatment
- Patient Education: Encourages informed decision-making and active participation in care
- Cultural Sensitivity: Adapts care to respect diverse patient backgrounds
- International Patient Support: Offers pre-consultations and guidance for patients from abroad
Professional Affiliations
Dr. Specht is a member of several prestigious oncology organizations, reflecting her commitment to professional development and leadership in her field.
- European Society for Radiotherapy and Oncology (ESTRO)
- American Society for Radiation Oncology (ASTRO)
- Danish Society for Oncology
- General Medical Council (UK): Registered since 1982
- National Board of Health, Denmark: Registered since 1979
FAQs
- Is Dr. Lena Specht board-certified?
- Yes, she is registered with the Danish National Board of Health and the UK General Medical Council.
- What types of surgeries does she perform?
- Dr. Specht is a radiation oncologist and does not perform surgical procedures.
- Does she treat international patients?
- Yes, international patients can receive consultations and treatment under her care at Rigshospitalet.
- How long is the typical hospital stay?
- The duration varies depending on the type of treatment and patient-specific factors.
- What languages does she speak?
- Dr. Specht speaks Danish and English fluently, enabling effective communication with diverse patients.
- What are her main research interests?
- Her research focuses on lymphoma prognostic factors, late effects of cancer treatment, and advanced radiation therapy techniques.
- Can patients receive pre-treatment consultations online?
- Yes, international patients can access online pre-consultations to discuss treatment plans before traveling.
